By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Delcath Systems, Inc. 

1100 Summer Street, 3rd Floor

Stamford  Connecticut  06905  U.S.A.
Phone: 203-323-8668 Fax: 203-961-0120


Drug Delivery

Company News
Delcath Systems (DCTH)'s European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients 5/27/2015 9:59:55 AM
Delcath Systems (DCTH) Names Dr. Jennifer Simpson President And CEO 5/26/2015 7:36:12 AM
ICC Cohort Of Delcath Systems (DCTH)'s Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 5/21/2015 6:41:35 AM
Delcath Systems (DCTH) Reports 2015 First Quarter Financial Results 5/7/2015 7:59:59 AM
Delcath Systems (DCTH) Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 4/21/2015 11:30:54 AM
Delcath Systems (DCTH) To Present At Needham & Company's 14th Annual Healthcare Conference 4/10/2015 11:19:12 AM
Delcath Systems (DCTH) Trims Executive Team to Conserve Cash 4/9/2015 5:55:45 AM
Delcath Systems, Inc. (DCTH) Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program 4/7/2015 6:47:43 AM
Delcath Systems, Inc. (DCTH) Activates Prospective Registry In Europe 4/2/2015 8:27:56 AM
Data Highlighting Delcath Systems, Inc. (DCTH)'s Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3/27/2015 6:58:52 AM